Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03543852 · ClinicalTrials.gov registry record · NA
SurvivorLink: Scalability of an Electronic Personal Health Record
A NA study, sponsored by Emory University.
- Completed
- Registry status
- NA
- Development phase
- 580
- Enrollment target
NCT03543852 is a NA study that has completed, run by Emory University. The registered enrollment target is 580 participants.
The verdict
NCT03543852, a NA study, has completed, sponsored by Emory University.
- COMPLETED
- Registry status
- NA
- Development phase
- 580 participants
- Enrollment target
Study Summary
Previous research suggests that children and adolescents with cancer are at heightened risk of late effects that can occur months or years after cancer treatment, yet little is known about programs that increase their return for follow-up cancer care and late effects surveillance. This study will evaluate the impact of an electronic personal health record and education system, SurvivorLink, for pediatric cancer survivors and their caregivers. The researchers will develop a standardized intervention and training for the SurvivorLink trial, followed by conducting a Hybrid Type 1 effectiveness-implementation, clustered randomized, waitlist control trial to evaluate the impact of SurvivorLink on pediatric cancer patients' one year follow-up visits and completion of screening tests. The study will also assess the impact of SurvivorLink on caregiver's patient activation, survivor's and caregiver's quality of life, and self-efficacy to manage a chronic condition. This study will provide the evidence base about the effects of the system to improve follow-up care for children and adolescents with cancer and best practices for implementation for pediatric cancer centers.
Interventions
- BEHAVIORAL SurvivorLink
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 580 participants |
| Start Date | 2021-06-14 |
| Est. Completion | 2024-12-25 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03543852
The ClinicalTrials.gov registry entry for NCT03543852 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 580 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Emory University, which has 1,208 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which SurvivorLink is the first listed.
NCT03543852 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03543852 about?
NCT03543852 is a clinical study titled "SurvivorLink: Scalability of an Electronic Personal Health Record". Previous research suggests that children and adolescents with cancer are at heightened risk of late effects that can occur months or years after cancer treatment, yet little is known about programs that increase their return for follow-up cancer care and late effects surveillance. This study will ev...
What is the current status of trial NCT03543852?
This trial is currently completed. It is a NA study. The enrollment target is 580 participants. The study started on 2021-06-14. Estimated completion is 2024-12-25.
What interventions are being tested in trial NCT03543852?
The interventions under investigation include: SurvivorLink (BEHAVIORAL).
Who is sponsoring clinical trial NCT03543852?
This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.